[Botulinum A toxin treatment in patients with oromandibular dystonia with concomitant malnutrition].
Oromandibular dystonic movements may present a type of focal or segmental dystonia. They often cause the malnutrition problems and social isolation. The aim of the study was to evaluate the efficacy of Botulinum Toxin type A treatment in patients with oromandibular dystonia with estimation of nutrition status. 15 patients with oromandibular dystonia, 9 women and 6 men, mean age 56 years old, were investigated. In all patients Botulinum Toxin type A was administrated intramuscularly under the EMG control. In 14 patients the improvement was significant and in 11 increase body mass was observed within 6 month after injections. Botulinum Toxin type A is useful in treatment of oromandibular dystonic movements in patients with malnutrition.
Budrewicz
Sławomir
S
Koszewicz
Magdalena
M
Góral
Małgorzata
M
D019274:Botulinum Toxins, Type A / Q000008:administration & dosage / Q000627:therapeutic use*; D004421:Dystonia / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D004576:Electromyography; D005152:Facial Muscles / Q000503:physiopathology*; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D044342:Malnutrition / Q000150:complications*; D008334:Mandible; D008875:Middle Aged; D009465:Neuromuscular Agents / Q000008:administration & dosage / Q000627:therapeutic use*
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A